stoxline Quote Chart Rank Option Currency Glossary
  
Akoya Biosciences, Inc. (AKYA)
1.965  0.025 (1.29%)    05-24 16:00
Open: 1.95
High: 2.11
Volume: 446,981
  
Pre. Close: 1.94
Low: 1.95
Market Cap: 97(M)
Technical analysis
2024-05-24 4:51:03 PM
Short term     
Mid term     
Targets 6-month :  4.19 1-year :  5.43
Resists First :  3.59 Second :  4.65
Pivot price 3.21
Supports First :  1.87 Second :  1.56
MAs MA(5) :  2.32 MA(20) :  3.39
MA(100) :  4.61 MA(250) :  4.96
MACD MACD :  -0.6 Signal :  -0.4
%K %D K(14,3) :  2.7 D(3) :  2.7
RSI RSI(14): 19.1
52-week High :  8.8 Low :  1.87
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AKYA ] has closed above bottom band by 13.4%. Bollinger Bands are 185% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.11 - 2.13 2.13 - 2.14
Low: 1.92 - 1.93 1.93 - 1.95
Close: 1.94 - 1.97 1.97 - 1.99
Company Description

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Headline News

Sun, 19 May 2024
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q1 2024 Earnings Call Transcript - Insider Monkey

Sun, 19 May 2024
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Wed, 15 May 2024
Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $6.00 by Analysts at BTIG Research - Defense World

Wed, 15 May 2024
Akoya Biosciences (NASDAQ:AKYA) Given New $6.00 Price Target at Canaccord Genuity Group - Defense World

Mon, 13 May 2024
Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates - Zacks Investment Research

Mon, 13 May 2024
Akoya Biosciences Reports First Quarter 2024 Financial Results - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 49 (M)
Shares Float 18 (M)
Held by Insiders 11.3 (%)
Held by Institutions 71.6 (%)
Shares Short 1,040 (K)
Shares Short P.Month 988 (K)
Stock Financials
EPS -1.43
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.1
Profit Margin -65.6 %
Operating Margin -33.4 %
Return on Assets (ttm) -19.7 %
Return on Equity (ttm) -112.8 %
Qtrly Rev. Growth 24.7 %
Gross Profit (p.s.) 0
Sales Per Share 1.95
EBITDA (p.s.) -0.96
Qtrly Earnings Growth 0 %
Operating Cash Flow -51 (M)
Levered Free Cash Flow -34 (M)
Stock Valuations
PE Ratio -1.38
PEG Ratio 0
Price to Book value 1.78
Price to Sales 1
Price to Cash Flow -1.91
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android